ZALSENERTANT TETRAXETAN LUTETIUM

UNII:	KVX6NT56EN
Type:	INGREDIENT SUBSTANCE
Formula:	C₅₈H₈₁N₁₀O₁₃.Lu
Preferred Substance Name:	ZALSENERTANT TETRAXETAN LUTETIUM
InChIKey:	SYBWLMAFAJCNHB-UHFFFAOYSA-K
GSRS Full Record:	KVX6NT56EN i

1613286-06-8
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2-((3-((3-((4-(3-(((2-CARBOXYTRICYCLO(3.3.1.13,7)DEC-2-YL)AMINO)CARBONYL)-5-(2,6-DIMETHOXYPHENYL)-1H-PYRAZOL-1-YL)-3-(1-METHYLETHYL)BENZOYL)METHYLAMINO)PROPYL)METHYLAMINO)PROPYL)METHYLAMINO)-2-OXOETHYL)-, LUTETIUM
10-(2-((3-((3-((4-(3-(((2-CARBOXYTRICYCLO(3.3.1.13,7)DEC-2-YL)AMINO)CARBONYL)-5-(2,6-DIMETHOXYPHENYL)-1H-PYRAZOL-1-YL)-3-(1-METHYLETHYL)BENZOYL)METHYLAMINO)PROPYL)METHYLAMINO)PROPYL)METHYLAMINO)-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, LUTETIUM

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZALSENERTANT TETRAXETAN LUTETIUM

Synonyms and Mappings

Resources